CORT Gary Charles Robb sells $225K worth of shares
Jun 19, 2025, 4:35 AM
0.00%
What does CORT do
Corcept Therapeutics, based in Menlo Park, California, is a commercial-stage pharmaceutical company that markets Korlym for Cushing's syndrome and has a portfolio of selective cortisol modulators. Founded in 2004, it employs 352 people and offers around 1,000 compounds.
Gary Charles Robb sold 3,185 shares of CORT on 16 June at $70.77 per share, worth a total of $225K. They now own 13,364 CORT shares, or a 19% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
